🇺🇸 SP plus amodiaquine in United States

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

FDA authorised SP plus amodiaquine on 28 October 1981

Marketing authorisation

FDA — authorised 28 October 1981

Application: NDA018557
Marketing authorisation holder: ROCHE
Local brand name: FANSIDAR
Indication: TABLET — ORAL
Status: approved

Read official source →

Other Infectious Diseases approved in United States

Frequently asked questions

Is SP plus amodiaquine approved in United States?

Yes. FDA authorised it on 28 October 1981.

Who is the marketing authorisation holder for SP plus amodiaquine in United States?

ROCHE holds the US marketing authorisation.